US Patent Issued to REPRIEVE CARDIOVASCULAR on April 21 for "Measuring and/or detecting analytes in urine, and associated systems, devices, and methods" (American, Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,702, issued on April 21, was assigned to REPRIEVE CARDIOVASCULAR INC. (Milford, Mass.).

"Measuring and/or detecting analytes in urine, and associated systems, devices, and methods" was invented by Eric Conley (York, Maine), Jim Dillon (South Kingstown, R.I.), Howard Robert Levin (Teaneck, N.J.), Zoar Engelman (New York), Martin Peacock (Horten, Norway), Megha Shah (Milford, Mass.) and Andrew Victor Halpert (Brookeline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology is generally directed to flow cartridges configured to measure and/or detect analytes in urine. A representative flow cartridge includes a urine inlet config...